Outcomes Research & AMR:
Bringing Value to the Care Pathway: The Rising Role of Rapid Diagnostics
In the second of a three-part series, CIDRAP-ASP explores the role of outcomes research in making the value case for rapid diagnostics that help to identify infectious diseases and prevent antimicrobial resistance (AMR).
The report also features two case studies on the role of outcomes research in: 1) clarifying the cost-effectiveness of rapid diagnostics for sepsis in different health contexts and 2) evaluating the cost-effectiveness of rapid diagnostics for invasive fungal infections in people living with HIV in Guatemala.
Our underwriters
Grant support for ASP provided by
